The Journal of Pediatrics
Volume 153, Issue 1 , Pages 71-75 , July 2008

Serum Amyloid A Concentration is Increased in Obese Children and Adolescents

  • Javier Gómez-Ambrosi, PhD

      Affiliations

    • From the Metabolic Research Laboratory, Clínica Universitaria de Navarra, University of Navarra, Pamplona, Spain
    • CIBER (CB06/03) Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, Madrid, Spain.
    • ,
  • Cristina Azcona, MD, PhD

      Affiliations

    • Department of Pediatrics, Clínica Universitaria de Navarra, University of Navarra, Pamplona, Spain
    • ,
  • Ana Patiño-García, PhD

      Affiliations

    • Department of Pediatrics, Clínica Universitaria de Navarra, University of Navarra, Pamplona, Spain
    • ,
  • Gema Frühbeck, RNutr, MD, PhD

      Affiliations

    • From the Metabolic Research Laboratory, Clínica Universitaria de Navarra, University of Navarra, Pamplona, Spain
    • Department of Endocrinology, Clínica Universitaria de Navarra, University of Navarra, Pamplona, Spain
    • CIBER (CB06/03) Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, Madrid, Spain.
    • Corresponding Author InformationReprint requests: Gema Frühbeck, RNutr, MD, PhD, Department of Endocrinology, Clínica Universitaria de Navarra, Avda. Pío XII 36, 31008-Pamplona, Spain.

Received 19 September 2007 ,Revised 26 November 2007 ,Accepted 9 January 2008.

References 

  1. Frühbeck G. Hunting for new pieces to the complex puzzle of obesity. Proc Nutr Soc. 2006;65:329–347
  2. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444:860–867
  3. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836–843
  4. Malle E, De Beer FC. Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice. Eur J Clin Invest. 1996;26:427–435
  5. Urieli-Shoval S, Linke RP, Matzner Y. Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states. Curr Opin Hematol. 2000;7:64–69
  6. Morrow DA, Rifai N, Antman EM, Weiner DL, McCabe CH, Cannon CP, et al. Serum amyloid A predicts early mortality in acute coronary syndromes: A TIMI 11A substudy. J Am Coll Cardiol. 2000;35:358–362
  7. Jousilahti P, Salomaa V, Rasi V, Vahtera E, Palosuo T. The association of C-reactive protein, serum amyloid A and fibrinogen with prevalent coronary heart disease: baseline findings of the PAIS project. Atherosclerosis. 2001;156:451–456
  8. Delanghe JR, Langlois MR, De Bacquer D, Mak R, Capel P, Van Renterghem L, et al. Discriminative value of serum amyloid A and other acute-phase proteins for coronary heart disease. Atherosclerosis. 2002;160:471–476
  9. Sjöholm K, Palming J, Olofsson LE, Gummesson A, Svensson PA, Lystig TC, et al. A microarray search for genes predominantly expressed in human omental adipocytes: adipose tissue as a major production site of serum amyloid A. J Clin Endocrinol Metab. 2005;90:2233–2239
  10. Danesh J, Muir J, Wong YK, Ward M, Gallimore JR, Pepys MB. Risk factors for coronary heart disease and acute-phase proteins: a population-based study. Eur Heart J. 1999;20:954–959
  11. van Dielen FM, van't Veer C, Schols AM, Soeters PB, Buurman WA, Greve JW. Increased leptin concentrations correlate with increased concentrations of inflammatory markers in morbidly obese individuals. Int J Obes Relat Metab Disord. 2001;25:1759–1766
  12. Poitou C, Viguerie N, Cancello R, De Matteis R, Cinti S, Stich V, et al. Serum amyloid A: production by human white adipocyte and regulation by obesity and nutrition. Diabetologia. 2005;48:519–528
  13. Gómez-Ambrosi J, Salvador J, Rotellar F, Silva C, Catalán V, Rodríguez A, et al. Increased serum amyloid A concentrations in morbid obesity decrease after gastric bypass. Obes Surg. 2006;16:262–269
  14. Yang RZ, Lee MJ, Hu H, Pollin TI, Ryan AS, Nicklas BJ, et al. Acute-phase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications. PLoS Med. 2006;3:e287
  15. O'Brien KD, Brehm BJ, Seeley RJ, Bean J, Wener MH, Daniels S, et al. Diet-induced weight loss is associated with decreases in plasma serum amyloid A and C-reactive protein independent of dietary macronutrient composition in obese subjects. J Clin Endocrinol Metab. 2005;90:2244–2249
  16. Poitou C, Coussieu C, Rouault C, Coupaye M, Cancello R, Bedel JF, et al. Serum amyloid A: a marker of adiposity-induced low-grade inflammation but not of metabolic status. Obesity. 2006;14:309–318
  17. Retnakaran R, Zinman B, Connelly PW, Harris SB, Hanley AJ. Nontraditional cardiovascular risk factors in pediatric metabolic syndrome. J Pediatr. 2006;148:176–182
  18. Economou EV, Malamitsi-Puchner AV, Pitsavos CP, Kouskouni EE, Magaziotou-Elefsinioti I, Creatsas G. Low-grade systemic inflammation profile, unrelated to homocysteinemia, in obese children. Mediators Inflamm. 2005;2005:337–342
  19. Speiser PW, Rudolf MC, Anhalt H, Camacho-Hubner C, Chiarelli F, Eliakim A, et al. Childhood obesity. J Clin Endocrinol Metab. 2005;90:1871–1887
  20. Fields DA, Higgins PB, Radley D. Air-displacement plethysmography: here to stay. Curr Opin Clin Nutr Metab Care. 2005;8:624–629
  21. Elberg J, McDuffie JR, Sebring NG, Salaita C, Keil M, Robotham D, et al. Comparison of methods to assess change in children's body composition. Am J Clin Nutr. 2004;80:64–69
  22. Azcona C, Köek N, Frühbeck G. Fat mass by air-displacement plethysmography and impedance in obese/non-obese children and adolescents. Int J Pediatr Obes. 2006;1:176–182
  23. Gungor N, Saad R, Janosky J, Arslanian S. Validation of surrogate estimates of insulin sensitivity and insulin secretion in children and adolescents. J Pediatr. 2004;144:47–55
  24. Gunczler P, Lanes R. Relationship between different fasting-based insulin sensitivity indices in obese children and adolescents. J Pediatr Endocrinol Metab. 2006;19:259–265
  25. Lin Y, Rajala MW, Berger JP, Moller DE, Barzilai N, Scherer PE. Hyperglycemia-induced production of acute-phase reactants in adipose tissue. J Biol Chem. 2001;276:42077–42083
  26. Jernas M, Palming J, Sjöholm K, Jennische E, Svensson PA, Gabrielsson BG, et al. Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression. FASEB J. 2006;20:1540–1542
  27. Connelly PW, Hanley AJ, Harris SB, Hegele RA, Zinman B. Relation of waist circumference and glycemic status to C-reactive protein in the Sandy Lake Oji-Cree. Int J Obes Relat Metab Disord. 2003;27:347–354
  28. Helmersson J, Vessby B, Larsson A, Basu S. Association of type 2 diabetes with cyclooxygenase-mediated inflammation and oxidative stress in an elderly population. Circulation. 2004;109:1729–1734
  29. van der Westhuyzen DR, Cai L, de Beer MC, de Beer FC. Serum amyloid A promotes cholesterol efflux mediated by scavenger receptor B-I. J Biol Chem. 2005;280:35890–35895
  30. Lewis KE, Kirk EA, McDonald TO, Wang S, Wight TN, O'Brien KD, et al. Increase in serum amyloid A evoked by dietary cholesterol is associated with increased atherosclerosis in mice. Circulation. 2004;110:540–545
  31. Tannock LR, O'Brien KD, Knopp RH, Retzlaff B, Fish B, Wener MH, et al. Cholesterol feeding increases C-reactive protein and serum amyloid A levels in lean insulin-sensitive subjects. Circulation. 2005;111:3058–3062
  32. Lago F, Dieguez C, Gómez-Reino J, Gualillo O. The emerging role of adipokines as mediators of inflammation and immune responses. Cytokine Growth Factor Rev. 2007;18:313–325

 Supported by grants from the Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Spain (FIS PI030381 and FIS PI061458) and the Department of Health of the Gobierno de Navarra, Spain (48/2003 and 20/2005).

 The authors have no conflicts of interest to report.

PII: S0022-3476(08)00009-7

doi: 10.1016/j.jpeds.2008.01.006

The Journal of Pediatrics
Volume 153, Issue 1 , Pages 71-75 , July 2008

Article Tools

* Image Usage & Resolution